7.55
+0.10
+(1.34%)
At close: April 17 at 8:03:52 AM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 45.96M | 47.17M | 190.75M | 202.68M |
Low Estimate | 45.68M | 46.9M | 189.2M | 197.8M |
High Estimate | 46.18M | 47.43M | 192.7M | 209.5M |
Year Ago Sales | 42.14M | 41.73M | 172.4M | 190.75M |
Sales Growth (year/est) | 9.08% | 13.04% | 10.65% | 6.25% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
XHC.F | -- | -- | -- | -- |
S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 1/27/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 1/24/2025 |
Maintains | Piper Sandler: Overweight to Overweight | 7/26/2024 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 7/26/2024 |
Maintains | Piper Sandler: Overweight to Overweight | 4/26/2024 |
Maintains | Piper Sandler: Overweight to Overweight | 1/26/2024 |